Resources from the same session
Introduction and scientific background
Presenter: Sjoukje Oosting
Session: Immunotherapy for head and neck cancer: What, when and how long?
Resources:
Slides
Webcast
Perioperative immunotherapy for head and neck squamous cell carcinoma (HNSCC)
Presenter: Athanassios Argiris
Session: Immunotherapy for head and neck cancer: What, when and how long?
Resources:
Slides
Webcast
Incorporating immunotherapy into the approach to locally advanced HNSCC
Presenter: Kevin Harrington
Session: Immunotherapy for head and neck cancer: What, when and how long?
Resources:
Slides
Webcast
Novel combinations in the non-curative HNSCC setting
Presenter: Brigette Ma
Session: Immunotherapy for head and neck cancer: What, when and how long?
Resources:
Slides
Webcast
Patient selection is crucial to improve immunotherapy effectiveness
Presenter: Sjoukje Oosting
Session: Immunotherapy for head and neck cancer: What, when and how long?
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Melvin Lee Kiang Chua
Session: Immunotherapy for head and neck cancer: What, when and how long?
Resources:
Slides
Webcast